This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Christopher v. SmithKline Beecham Corp. | |
|---|---|
| Litigants | Christopher v. SmithKline Beecham Corp. |
| Argued | October 7, 2012 |
| Decided | February 20, 2012 |
| Docket | No. 10-1018 |
| Citation | 132 S. Ct. 2156, 182 L. Ed. 2d 262 (2012) |
| Prior | Decision for petitioners, Ninth Circuit |
| Majority | Alito |
| Joinmajority | Roberts, Scalia, Kennedy, Thomas, Breyer |
| Dissent | Sotomayor (joined by Ginsburg) |
Christopher v. SmithKline Beecham Corp. Christopher v. SmithKline Beecham Corp. was a United States Supreme Court case concerning the interpretation of the Fair Labor Standards Act and the exemption for "outside salesmen", implicating labor law, employment litigation, federal appellate procedure, and administrative law in the context of pharmaceutical sales practices. The decision clarified statutory construction principles under the Fair Labor Standards Act and addressed the interplay between the Department of Labor, circuit precedent, and plenary review by the Supreme Court.
The case arose against the backdrop of litigation involving the Fair Labor Standards Act of 1938 and longstanding disputes about exemptions first examined in cases such as Encino Motorcars, LLC v. Navarro and administrative interpretations by the United States Department of Labor. The dispute involved pharmaceutical sales representatives, the Ninth Circuit Court of Appeals, and employers including SmithKline Beecham Corporation, a subsidiary of GlaxoSmithKline, with counsel and advocacy drawing on precedents from the United States Supreme Court, the United States Court of Appeals for the Ninth Circuit, and earlier labor decisions like Walling v. Jacksonville Paper Co..
Petitioners were sales representatives employed by SmithKline Beecham Corporation who marketed prescription pharmaceuticals to physicians and requested overtime compensation under the Fair Labor Standards Act of 1938, while respondents included corporate employers and corporate entities such as GlaxoSmithKline. The Ninth Circuit Court of Appeals held that the "outside salesman" exemption did not apply to pharmaceutical detailers based on its interpretation of the statute and prior circuit precedent, a ruling that conflicted with decisions from other circuits including the Third Circuit and the Seventh Circuit, prompting a petition for certiorari to the Supreme Court of the United States.
The principal questions presented included whether pharmaceutical sales representatives qualified for the "outside salesman" exemption in the Fair Labor Standards Act of 1938 and whether the Court should defer to an agency interpretation from the United States Department of Labor or instead accord weight to circuit precedent from the Ninth Circuit Court of Appeals and conflicting approaches by courts such as the Second Circuit Court of Appeals and the D.C. Circuit Court of Appeals. The case implicated doctrines developed in cases like Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc. and Skidmore v. Swift & Co. concerning judicial deference and statutory interpretation.
In a majority opinion authored by Samuel Alito, the Supreme Court of the United States reversed the Ninth Circuit and held that the statutory exemption for "outside salesmen" applied to pharmaceutical sales representatives under the Fair Labor Standards Act of 1938. The majority opinion drew on statutory language and decisions from prior cases including Tennessee Coal, Iron & Railroad Co. v. Muscoda Local No. 1235 and addressed administrative guidance issued by the United States Department of Labor. The Court granted certiorari despite earlier decisions from circuits such as the Third Circuit Court of Appeals and the Seventh Circuit Court of Appeals that had reached similar conclusions, thereby resolving a circuit split.
The Court's reasoning emphasized textual analysis of the Fair Labor Standards Act of 1938 and precedent regarding exemptions such as in Walling v. Jacksonville Paper Co., applying ordinary meaning and statutory construction canons found in decisions like Caminetti v. United States and MCI Telecommunications Corp. v. AT&T Co.. The majority discounted the persuasive force of the United States Department of Labor's interpretation, invoking principles from Skidmore v. Swift & Co. regarding deference where agency positions lack the force of law, and distinguishing Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc. where statutory ambiguity is amenable to formal agency rulemaking. The opinion discussed factual nuances of pharmaceutical detailers' activities compared to outside salesmen analyzed in cases such as Walling v. Jacksonville Paper Co. and policy considerations referenced in labor decisions like Nationwide Mut. Ins. Co. v. Darden.
Justice Sonia Sotomayor authored a dissent joined by Justice Ruth Bader Ginsburg, arguing that the majority misapplied deference doctrines and undervalued the Department of Labor's interpretation and regulatory history concerning sales exemptions under the Fair Labor Standards Act of 1938. The dissent cited interpretive precedents and administrative practice, drawing comparisons to decisions such as Auer v. Robbins and critiquing the majority's approach to statutory ambiguity and the role of agency guidance in employment standards adjudication, while referencing circuit decisions from the Ninth Circuit and scholars of employment law.
The ruling affected wage-and-hour litigation nationwide involving pharmaceutical representatives and prompted employers like GlaxoSmithKline and other industry actors to revise compensation policies in light of the decision, influencing compliance guidance from the United States Department of Labor and litigation strategies in circuits including the Second Circuit and the D.C. Circuit Court of Appeals. The decision has been cited in subsequent Supreme Court and circuit opinions addressing statutory exemptions and agency deference, shaping litigation in cases invoking doctrines from Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc. and Skidmore v. Swift & Co., and influencing academic commentary in law reviews at institutions such as Harvard Law School and Yale Law School.